ArticleTranslational andrology and urology2025
Identification of core genes in acute kidney injury: evidence from multi-omics human transcriptomic data and
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute kidney injury (AKI) affects up to 23.2% of hospitalized patients, but its complex pathophysiology hinders diagnosis and treatment. Bioinformatics-driven identification of core genes from large-scale omics data offers a promising approach for uncovering diagnostic and therapeutic targets. This study aims to integrate multi-omics data with experimental validation to identify core genes involved in AKI and explore their mechanisms. Methods: We analyzed renal transcriptomic data from 67 AKI patients and 20 controls, integrating differential expression, weighted gene co-expression network analysis (WGCNA), and clinical correlations to identify key genes. A nomogram model was used to assess diagnostic performance, and immune microenvironment characteristics were analyzed using CIBERSORT. AKI was induced in mice by ischemia-reperfusion and cisplatin, with gene expression validated by reverse transcription real-time quantitative polymerase chain reaction (RT-qPCR), Western blot, and immunohistochemistry. Results: Three core genes, epidermal growth factor ( Conclusions: This study highlights three core genes of AKI, especially
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.